Synthetic Peptides and Peptidomimetics: From Basic Science to Biomedical Applications
This Special Issue, entitled "Synthetic Peptides and Peptidomimetics: From Basic Science to Biomedical Applications", has included both reviews and original research contributions focused on the chemical design and biomedical applications of structurally modified bioactive peptides. The pa...
Saved in:
| HerausgeberIn: | |
|---|---|
| Sonstige: | |
| Year of Publication: | 2022 |
| Language: | English |
| Physical Description: | 1 electronic resource (274 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04665nam-a2201321z--4500 | ||
|---|---|---|---|
| 001 | 993545022804498 | ||
| 005 | 20231214133432.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202207s2022 xx |||||o ||| 0|eng d | ||
| 035 | |a (CKB)5690000000011980 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/87450 | ||
| 035 | |a (EXLCZ)995690000000011980 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Doti, Nunzianna |4 edt | |
| 245 | 1 | 0 | |a Synthetic Peptides and Peptidomimetics: From Basic Science to Biomedical Applications |
| 246 | |a Synthetic Peptides and Peptidomimetics | ||
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (274 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a This Special Issue, entitled "Synthetic Peptides and Peptidomimetics: From Basic Science to Biomedical Applications", has included both reviews and original research contributions focused on the chemical design and biomedical applications of structurally modified bioactive peptides. The papers collected show how successful this class of molecules still is, both as model molecules for studying the structure of proteins and as potential therapeutics and diagnostics, and also as laboratory tools for advanced basic and applied studies. The large scientific community working in this field is in fact very active and productive, and is making the most of the potential and versatility of these molecules to generate increasingly interesting and innovative molecules of therapeutic interest and to understand the fundamental molecular mechanisms of life. | ||
| 546 | |a English | ||
| 650 | 7 | |a Research & information: general |2 bicssc | |
| 650 | 7 | |a Biology, life sciences |2 bicssc | |
| 653 | |a polymers | ||
| 653 | |a peptidomimetics | ||
| 653 | |a AFM | ||
| 653 | |a transfection | ||
| 653 | |a molecular modelling | ||
| 653 | |a peptide | ||
| 653 | |a α-helix | ||
| 653 | |a hydrocarbon stapling | ||
| 653 | |a ring-closing metathesis | ||
| 653 | |a i,i + 1 staple | ||
| 653 | |a X-ray structure | ||
| 653 | |a deferoxamine | ||
| 653 | |a RGD peptides | ||
| 653 | |a integrins | ||
| 653 | |a radiodiagnostics | ||
| 653 | |a PET imaging | ||
| 653 | |a retro-inverso peptides | ||
| 653 | |a anticancer peptides | ||
| 653 | |a drug delivery | ||
| 653 | |a peptide antigens | ||
| 653 | |a Aβ | ||
| 653 | |a IAPP | ||
| 653 | |a antimicrobial peptides | ||
| 653 | |a peptides | ||
| 653 | |a diagnostic | ||
| 653 | |a ELISA | ||
| 653 | |a microarray | ||
| 653 | |a PET | ||
| 653 | |a SPECT | ||
| 653 | |a imaging diagnostic | ||
| 653 | |a non-imaging diagnostic | ||
| 653 | |a amphiphilic peptides | ||
| 653 | |a non-viral gene delivery | ||
| 653 | |a nanocarrier | ||
| 653 | |a peptide self-assemblies | ||
| 653 | |a stimuli responsive | ||
| 653 | |a SARS-CoV-2 | ||
| 653 | |a FRET | ||
| 653 | |a molecular docking | ||
| 653 | |a molecular dynamics | ||
| 653 | |a MM-GBSA | ||
| 653 | |a drug repurposing | ||
| 653 | |a antiviral | ||
| 653 | |a cancer | ||
| 653 | |a cyclic peptide | ||
| 653 | |a integrin | ||
| 653 | |a αvβ3 | ||
| 653 | |a ALOS4 | ||
| 653 | |a melanoma | ||
| 653 | |a fluorescent peptide | ||
| 653 | |a environment-sensitive fluorophore | ||
| 653 | |a peptide labeling | ||
| 653 | |a luciferin | ||
| 653 | |a membrane-binding peptide | ||
| 653 | |a antimicrobial peptide | ||
| 653 | |a antitumor peptide | ||
| 653 | |a RGD peptide | ||
| 653 | |a antiproliferative activity | ||
| 653 | |a chirality | ||
| 653 | |a conformational analysis | ||
| 653 | |a density functional theory (DFT) | ||
| 653 | |a ferrocene | ||
| 653 | |a hydrogen bonds | ||
| 653 | |a peptidomimetic | ||
| 653 | |a X-ray | ||
| 653 | |a protein–protein interactions (PPIs) | ||
| 653 | |a voltage-gated Na+ (Nav) channels | ||
| 653 | |a fibroblast growth factor 14 (FGF14) | ||
| 653 | |a medium spiny neurons (MSNs) | ||
| 653 | |a nucleus accumbens (NAc) | ||
| 653 | |a neurotherapeutics | ||
| 653 | |a cyclophilin A (CypA) | ||
| 653 | |a apoptosis-inducing factor (AIF) | ||
| 653 | |a human neuroblastoma SH-SY5Y cells | ||
| 653 | |a staurosporine-mediated cell death | ||
| 653 | |a AIF(370-394) peptide | ||
| 653 | |a caspase-3 | ||
| 653 | |a PARP | ||
| 653 | |a antifungal | ||
| 653 | |a antibacterial | ||
| 653 | |a peptide-based therapies | ||
| 653 | |a synthetic peptides | ||
| 776 | |z 3-0365-4396-1 | ||
| 776 | |z 3-0365-4395-3 | ||
| 700 | 1 | |a Ruvo, Menotti |4 edt | |
| 700 | 1 | |a Doti, Nunzianna |4 oth | |
| 700 | 1 | |a Ruvo, Menotti |4 oth | |
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:53:53 Europe/Vienna |f system |c marc21 |a 2022-07-14 08:50:39 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337829400004498&Force_direct=true |Z 5337829400004498 |b Available |8 5337829400004498 | ||